Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.36 |
| ▸ | UBE2N | P61088 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FHIT | P49789 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3362820 | 0.99 | MAOB (0.40) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL4182826 | 0.98 | MAOB (0.39) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| SCHEMBL3360474 | 0.98 | MAOA (0.42) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL4192607 | 0.97 | MAOA (0.41) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| SCHEMBL3359444 | 0.94 | MAOA (0.41) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| SCHEMBL8903963 | 0.93 | MAOA (0.41) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| SCHEMBL3360003 | 0.93 | MAOA (0.41) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL4193524 | 0.93 | MAOA (0.41) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| SCHEMBL3359425 | 0.93 | MAOA (0.44) | MAOBMAOAKDM4EALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL4188117 | 0.92 | MAOA (0.40) | MAOBMAOAKDM4EALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1508345-B1 | System and method for the reduction of small organic compounds from blood products | CERUS CORP (US) | 2013-09-25 | — | — | EP | claimed |
| US-7611831-B2 | Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix | CERUS CORPORATION (US) | 2009-11-03 | — | — | US | claimed |
| EP-1776952-A2 | Photodecontamination of pathogens in blood | Cerus Corporation (US) | 2007-04-25 | — | — | EP | claimed |
| EP-0707476-B1 | COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD | CERUS CORP (US) | 2007-02-14 | — | — | EP | claimed |
| US-20060093999-A1 | For reducing the concentration of low molecular weight compounds in a biological composition containing cells while substantially maintaining a desired biological activity; comprises highly porous adsorbent particles | CERUS CORPORATION | 2006-05-04 | — | — | US | claimed |
| US-7037642-B2 | Removing compounds from blood products with porous particles immobilized in a matrix | CERUS CORPORATION (US) | 2006-05-02 | — | — | US | claimed |
| US-6951713-B2 | Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix | CERUS CORPORATION (US) | 2005-10-04 | — | — | US | claimed |
| US-20050142542-A1 | ABSORBING PATHOGEN-INACTIVATING COMPOUNDS WITH POROUS PARTICLES IMMOBILIZED IN A MATRIX | CERUS CORPORATION | 2005-06-30 | — | — | US | claimed |
| EP-1508345-A1 | Absorbents and devices for the reduction of small organic compounds from blood products | Cerus Corporation (US) | 2005-02-23 | — | — | EP | claimed |
| EP-0954374-B1 | ADSORBENS AND DEVICES FOR THE REDUCTION OF SMALL ORGANIC COMPOUNDS FROM BLOOD PRODUCTS | CERUS CORP (US) | 2004-11-24 | — | — | EP | claimed |
| US-5593823-A | FOR A SUFFICIENT DURATION, INTENSITY AND WAVELENGTH | CERUS CORPORATION (US) | 1997-01-14 | — | — | US | claimed |
| US-20180185484-A1 | PREPARATION AND USE OF PLATELET PRODUCTS | MIDCAP FINANCIAL TRUST | 2018-07-05 | — | — | US | disclosed |
| EP-3247351-A1 | PREPARATION AND USE OF PLATELET PRODUCTS | Cerus Corporation (US) | 2017-11-29 | — | — | EP | disclosed |
| US-20160354533-A1 | ADSORBING PATHOGEN-INACTIVATING COMPOUNDS WITH POROUS PARTICLES IMMOBILIZED IN A MATRIX | CERUS CORPORATION (US) | 2016-12-08 | — | — | US | disclosed |
| WO-2016115535-A1 | PREPARATION AND USE OF PLATELET PRODUCTS | CERUS CORPORATION (US) | 2016-07-21 | — | — | WO | disclosed |
| WO-1997021346-A1 | INACTIVATION OF NON-ENVELOPED VIRUS | CERUS CORPORATION (US) | 1997-06-19 | — | — | WO | disclosed |
| WO-1996039820-A1 | METHODS OF INACTIVATING LEUKOCYTES AND INHIBITING CYTOKINE PRODUCTION IN BLOOD PRODUCTS | CERUS CORPORATION (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996014739-A1 | COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD | CERUS CORPORATION (US) | 1996-05-23 | — | — | WO | disclosed |
| EP-0707476-A1 | COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD | STERITECH, INC (US) | 1996-04-24 | — | — | EP | disclosed |
| WO-1995000141-A1 | COMPOUNDS FOR THE PHOTODECONTAMINATION OF PATHOGENS IN BLOOD | STERITECH, INC. (US) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180185484-A1 | PREPARATION AND USE OF PLATELET PRODUCTS | PLTP, MPL, PFKP | MAOB 3017/4885MAOA 3650/4885KDM4E 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.